Enlivex Therapeutics (ENLV)
(Delayed Data from NSDQ)
$1.48 USD
-0.03 (-1.99%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $1.48 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Enlivex Therapeutics (ENLV) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.22 per share. This reflects a positive earnings surprise of 27.27%. Look out for ENLV's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for ENLV
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
ENLV: What are Zacks experts saying now?
Zacks Private Portfolio Services